Personalised cellular therapy gives Hunter a future
A cutting-edge cellular therapy, made possible by breakthrough research, has given seven-year-old Hunter hope for a brighter future.
- Acute lymphoblastic leukaemia
A cutting-edge cellular therapy, made possible by breakthrough research, has given seven-year-old Hunter hope for a brighter future.
Dr Michelle Henderson's research is laying the groundwork to develop a promising new therapy for infant ALL.
New York-based, Aussie researcher Matt Witkowski has his sights set on improving the effectiveness of CAR T-cell therapy.
Archer spent nine months, hundreds of kilometres from home and across state borders, undergoing life-saving blood cancer treatment during the COVID-19 pandemic.
To mark September’s Childhood Cancer Awareness Month, we’re sharing the inspiring stories of little warriors like Daisy, who was diagnosed with an aggressive blood cancer at just four months old.
Gavin thought leukaemia was only a children’s cancer until the day his shock diagnosis completely changed his family forever.
This year’s will be Sarah’s second Mother’s Day – but the first she’ll be celebrating cancer free.
Gavin received a transplant to treat his ALL from an unrelated-matched donor.
Ari’s family told us about the impact the virus has on their lives.
Better understanding and treating myeloma is the focus of eight research projects that are part of the Leukaemia Foundation’s National Research Program.